期刊文献+

四氢生物蝶呤对吸烟者大隐静脉桥内皮功能的影响 被引量:4

Effect of tetrahydrobiopterin on endothelium function of the great saphenous vein from smokers
原文传递
导出
摘要 目的观察四氢生物蝶呤(BH。)对吸烟者大隐静脉桥内皮功能的影响。方法取12例吸烟(实验组)及10例不吸烟(对照组)行冠状动脉旁路移植术患者的大隐静脉。在器官槽中观察经重碳酸盐缓冲液(KH液)、含0.1mol/LN.硝基.L一精氨酸(L—NNA)或含20p,mol/LBH。的KH液浸泡30min后,苯肾上腺素(1×10^-5mol/L)及不同浓度(1××10^-9-1×10^-5mol/L)的非受体介导钙离子载体引发的血管舒缩反应。结果最大收缩强度各组间差异无统计学意义(P〉0.05)。最大舒张反应:经KH液浸泡后实验组低于对照组[(29.50±6.22)%比(48.20±7.74)%,P〈0.01];经L.NNA[(24.50±5.72)%比(28.80±5.64)%]或BH。[(46.40±6.32)%比(50.80±6.91)%]浸泡后两组差异无统计学意义(P〉0.05)。结论吸烟损伤大隐静脉桥内皮源性一氧化氮介导的血管舒张功能,BH。有利于此功能的恢复。 Objective To observe the effect of tetrahydrobiopterin (BH4) on endothelium function of the great saphenous vein from smokers. Methods The rings of great saphenous vein were selected from 22 patients with coronary artery bypass grafting, which including smoking (experimental group, n = 12) and non-smoking (control group, n = 10) patients. After incubation in Krebs-Henseleit ( KH), KH plus BH4 (20 p.mol/L) or N-nitro-L-arginine (L-NNA, 0. 1 tool/L), the vasoconstriction and vasodilatation were induced by phenylephrine (1 ×10^-5mol/L) and non-receptor-mediated calcium ionophore (A23187, 1 ×10^-9-1 ×10^-5mol/L) separately in an organ chamber. Results The maximum constriction in all groups had no significant difference (P 〉 0. 05 ). The maximum relaxation was significantly decreased in experimental group as compared with control group [ (29. 50 ±6. 22)% vs (48.20 ±7. 74)% ,P 〈0. 01 ] after incubation in KH, while there was no significant difference ( P 〉 0. 05 ) after incubation in KH plus L-NNA [ (24. 50 ± 5.72) % vs (28.8 ± 5.64) % ] or BH4 [ (46.40 ± 6.32) % vs ( 50. 80 ± 6.91 ) % ]. Conclusion Smoking impairs the relaxation funetion mediated by endothelium-derived nitric oxide in great saphenous, which may be restored by BH4.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第4期520-522,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:广西教育厅科研基金资助项目(200710MSl52)
关键词 吸烟 大隐静脉 内皮功能 冠状动脉旁路移植术 Smoking Great saphenous vein Endothelium function CABG
  • 相关文献

参考文献7

  • 1Li H, Ftirstermann U. Prevention of atheroselerosis by interference with the vascular nitric oxide system. Curr Pharm Des, 2009, 15:3133- 3145.
  • 2Winkelmann BR, von Holt K, Unverdorben M. Smoking and atherosclerotic cardiovascular disease : Part I : atherosclerotic disease process. Biomark Med,2009,3:411-428.
  • 3李军,陈涛,朱冰,潘铁成,洪梅.移植血管自身的内膜增生和TGF-β1的局部表达在移植血管病变发生机制中的作用[J].中华实验外科杂志,2007,24(6):709-711. 被引量:3
  • 4李世康,龙村,程邦昌,刘唐威,何巍,陈铭伍,史世勇.组氨酸-色氨酸-酮戊二酸与威斯康星大学溶液对冠状动脉内皮细胞的影响[J].中华实验外科杂志,2003,20(4):309-310. 被引量:7
  • 5Schwartz BG, Economides C, Mayeda GS, et al. The endothelial cell in health and disease : its function, dysfunction, measurement and therapy. Int J Impot Res,2010,22:77-90.
  • 6Unverdorben M, von Holt K, Winkelmann BR. Smoking and athero- sclerotic cardiovascular disease : part Ⅱ: role of cigarette smoking in cardiovascular disease development. Biomark Med,2009,3:617-653.
  • 7Katusic ZS, d' Uscio LV, Nath KA. Vascular protection by tetrahydrobiopterin : progress and therapeutic prospects. Trends Pharmacol Sci, 2009,30:48-54.

二级参考文献14

  • 1Fitzgibbon GM, Kafka HP, Leach A J, et al. Coronary bypass graft fate and patient outcome : angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol, 1996,28:616-626.
  • 2Shelton ME, Forman MB, Virmani R, et al. A comparison of morphologic and angiographic findings in long-term internal mammary artery and saphenous vein bypass grafts. J Am Coll Cardiol, 1988,11:297- 307.
  • 3Song RH,Kocharyan HK,Fortunato JE,et al. Increased flow and shear stress enhance in vivo transforming growth factor-β1 after experimental arterial injury. Arterioscler Thromb Vasc Biol,2000,20:923- 930.
  • 4Waltenberger J. Modulation of growth factor action : implications for the treatment of cardio- vascular diseases. Circulation, 1997,96:4083- 4094.
  • 5Stracke S, Konner K, Kostlin I, et al. Increased expression of TGF-β1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int ,2002,61 : 1011-1019.
  • 6Waltenberger J, Lundin L, Wilander E, et al. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol, 142:71-78.
  • 7Kanzaki T,Tamura K,Takahashi K,et al. In vivo effect of TGF-β 1. Enhanced intimal thickening by administration of TGF-β 1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol, 1995,15 : 1951-1957.
  • 8Wilson YG, Davies AH, Southgate K, et al. Vein quality influences neointimal hyperplasia in an organ culture model of human saphenous veins. Eur J Vasc Surg,1997 ,13 :557-562.
  • 9Dattilo JB, Lust RM, Dattilo MP, et al. The temporal expression of transforming growth factor-β 1 in early aortocoronary vein grafts. J Surg Res, 1997,69:349-353.
  • 10Hoch JR, Stark VK, Turnipseed WD. The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression. J Vasc Surg, 1995,22:51-58.

共引文献8

同被引文献25

  • 1李世康,龙村,何巍,彭青云,周华富,郭建极.高钾停搏液中镁离子对冠状动脉张力的影响[J].中华胸心血管外科杂志,2006,22(4):259-261. 被引量:8
  • 2Mehta RH,Honeycutt E,Shaw LK,et al.Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions.Am Heart J,2008,156:728-735.
  • 3Ozkor MA,Quyyumi AA.Tetrabydrobiopterin.Curr Hypertens Rep,2008,10:58-64.
  • 4Wong WT,Wong SL,Tian XY,et al.Endothelial dysfunction:the common consequence in diabetes and hypertension.J Cardiovasc Pharmacol,2010,55:300-307.
  • 5Guzik TJ,Mussa S,Gastaldi D,et al.Mechanisms of increased vascular superoxide production in human diabetes mellitus:role of NAD (P)H oxidase and endothelial nitric oxide synthase.Circulation,2002,105:1656-1662.
  • 6Siscovick DS, Sotoodehnia N, Rea TD, et al. Type 2 diabetes melli- tus and the risk of sudden cardiac arrest in the community. Rev En- docr Metab Disord, 2010,11:53 - 59.
  • 7Arima M, Kanoh T, Suzuki T, et al. Serial angiographic follow-up beyond 10 years after coronary artery bypass grafting. Circ J, 2005, 69 : 896 - 902.
  • 8Mehta RH, Honeycutt E, Shaw LK, et al. Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions. Am Heart J, 2008,156:728 -735.
  • 9Lorusso R, De Cicco G, Beghi C, et al. Functional effects of nitric oxide - releasing aspirin on vein conduits of diabetic patients under- going CABG. Int J Cardiol, 2007,118:164 - 169.
  • 10Vander Heide R. Clinically useful cardioprotection:ische- mic preconditioning then and now[J]. J Cardiovasc Phar- macol Ther,2011,16(2) :251-254.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部